Literature DB >> 18497723

Insulin resistance and the metabolic syndrome.

D Lann1, E Gallagher, D Leroith.   

Abstract

The metabolic syndrome is a constellation of risk factors including glucose dysregulation, central obesity, dyslipidemia, and hypertension. There are multiple definitions that have been described by various health organizations. However, we do know that insulin resistance plays a major role as the underlying cause for the development and potentiation of the metabolic syndrome. At present, it is unclear if the diagnosis of metabolic syndrome is greater than the sum of its parts. However, the presence of more than one of the associated risk factors should indicate that a patient is at increased risk for developing diabetes, cardiovascular disease and death. Thus, the primary care physician should aggressively treat the metabolic risk factors in their patients to prevent the onset and progression to more severe disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497723

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  3 in total

1.  Helicobacter pylori and insulin resistance: time to do interventional studies.

Authors:  Rinaldo Pellicano; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2009-09-30       Impact factor: 3.199

Review 2.  Impact of dietary polyphenols on carbohydrate metabolism.

Authors:  Kati Hanhineva; Riitta Törrönen; Isabel Bondia-Pons; Jenna Pekkinen; Marjukka Kolehmainen; Hannu Mykkänen; Kaisa Poutanen
Journal:  Int J Mol Sci       Date:  2010-03-31       Impact factor: 5.923

3.  Human Macrophages Preferentially Infiltrate the Superficial Adipose Tissue.

Authors:  Giuseppe Cappellano; Evi M Morandi; Johannes Rainer; Philipp Grubwieser; Katharina Heinz; Dolores Wolfram; David Bernhard; Susanne Lobenwein; Gerhard Pierer; Christian Ploner
Journal:  Int J Mol Sci       Date:  2018-05-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.